Drug Targets in Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection

Publisher： Bentham Science Publishers

E-ISSN： 2212-3989|9|2|159-171

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.9, Iss.2, 2009-04, pp. : 159-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiretrovirals: Human T lymphotropic virus type (HTLV) 1-associated myelopathy/tropical spastic paraparesis in a patient with HIV and HTLV 2 coinfection: case report

By  

Reactions Weekly, Vol. 1, Iss. 1175, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Unexploited Viral and Host Targets for the Treatment of Human Immunodeficiency Virus Type 1 Infection

By  

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 107-123

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines as Drug Targets in Type 1 Diabetes

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 1, 2007-03 ,pp. : 7-12

Bentham Science Publishers

Access to resources Recommend Favorite

Roles of miRNAs in virus-mediated cellular transformation: lessons from human T-cell leukemia virus type 1

By Yeung Man Lung   Jeang Kuan-Teh  

Future Virology, Vol. 6, Iss. 11, 2011-11 ,pp. : 1351-1360

Future Medicine

Access to resources Recommend Favorite

Genetic Polymorphisms in the Chemokine and Chemokine Receptors: Impact on Clinical Course and Therapy of the Human Immunodeficiency Virus Type 1 Infection (HIV-1)

By  

Current Medicinal Chemistry, Vol. 14, Iss. 12, 2007-05 ,pp. : 1325-1334

Bentham Science Publishers

Access to resources Recommend Favorite